These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 12063741

  • 1. [Leflunomide--a new drug for pharmacological immunomodulation].
    Wozel G, Pfeiffer C.
    Hautarzt; 2002 May; 53(5):309-15. PubMed ID: 12063741
    [Abstract] [Full Text] [Related]

  • 2. Leflunomide for the treatment of rheumatoid arthritis and autoimmunity.
    Sanders S, Harisdangkul V.
    Am J Med Sci; 2002 Apr; 323(4):190-3. PubMed ID: 12003373
    [Abstract] [Full Text] [Related]

  • 3. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.
    Herrmann ML, Schleyerbach R, Kirschbaum BJ.
    Immunopharmacology; 2000 May; 47(2-3):273-89. PubMed ID: 10878294
    [Abstract] [Full Text] [Related]

  • 4. Leflunomide in dermatology.
    Boyd AS.
    J Am Acad Dermatol; 2012 Apr; 66(4):673-9. PubMed ID: 21962758
    [Abstract] [Full Text] [Related]

  • 5. Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
    Fragoso YD, Brooks JB.
    Expert Rev Clin Pharmacol; 2015 May; 8(3):315-20. PubMed ID: 25712857
    [Abstract] [Full Text] [Related]

  • 6. Leflunomide: dermatologic perspective.
    Sehgal VN, Verma P.
    J Dermatolog Treat; 2013 Apr; 24(2):89-95. PubMed ID: 21801113
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases.
    Frieling U, Luger TA.
    Clin Exp Dermatol; 2002 Oct; 27(7):562-70. PubMed ID: 12464151
    [Abstract] [Full Text] [Related]

  • 8. Leflunomide and malononitrilamides.
    Silva Júnior HT, Morris RE.
    Am J Med Sci; 1997 May; 313(5):289-301. PubMed ID: 9145039
    [Abstract] [Full Text] [Related]

  • 9. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.
    Bartlett RR, Dimitrijevic M, Mattar T, Zielinski T, Germann T, Rüde E, Thoenes GH, Küchle CC, Schorlemmer HU, Bremer E.
    Agents Actions; 1991 Jan; 32(1-2):10-21. PubMed ID: 2058454
    [Abstract] [Full Text] [Related]

  • 10. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Bartlett RR, Brendel S, Zielinski T, Schorlemmer HU.
    Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
    [No Abstract] [Full Text] [Related]

  • 11. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC, Orfanos-Boeckel H, Offermann G, Orfanos CE.
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of action for leflunomide in rheumatoid arthritis.
    Fox RI, Herrmann ML, Frangou CG, Wahl GM, Morris RE, Strand V, Kirschbaum BJ.
    Clin Immunol; 1999 Dec; 93(3):198-208. PubMed ID: 10600330
    [Abstract] [Full Text] [Related]

  • 13. The broadening use of leflunomide in clinical practice.
    Kiely PD.
    Hosp Med; 2004 Dec; 65(12):735-9. PubMed ID: 15624449
    [Abstract] [Full Text] [Related]

  • 14. Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis.
    Alldred A, Emery P.
    Expert Opin Pharmacother; 2001 Jan; 2(1):125-37. PubMed ID: 11336574
    [Abstract] [Full Text] [Related]

  • 15. Bullous pemphigoid treated with leflunomide: a novel immunomodulatory agent.
    Nousari HC, Anhalt GJ.
    Arch Dermatol; 2000 Oct; 136(10):1204-5. PubMed ID: 11030765
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of severe psoriasis and psoriatic arthritis with leflunomide.
    Reich K, Hummel KM, Beckmann I, Mössner R, Neumann C.
    Br J Dermatol; 2002 Feb; 146(2):335-6. PubMed ID: 11903256
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of leflunomide in active rheumatoid arthritis.
    Smolen JS, Emery P.
    Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():48-56. PubMed ID: 11001380
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
    Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R.
    Lancet; 1999 Jan 23; 353(9149):259-66. PubMed ID: 9929017
    [Abstract] [Full Text] [Related]

  • 19. Leflunomide for the treatment of rheumatoid arthritis.
    Miceli-Richard C, Dougados M.
    Expert Opin Pharmacother; 2003 Jun 23; 4(6):987-97. PubMed ID: 12783594
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy of leflunomide].
    Hirohata S.
    Nihon Rinsho; 2002 Dec 23; 60(12):2357-63. PubMed ID: 12510362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.